STOCK TITAN

Genvor Inc (GNVR) Financials

GNVR
Trailing 12 months to June 30, 2026
Revenue Not reported for the trailing 12 months
Net Income Not reported for the trailing 12 months
EPS (Diluted) -$0.09 YoY not available
Operating Cash Flow -$1.1M -151.3% YoY
Market Cap $13.5M as of Sep 2, 2026
Price / Sales n/m no revenue reported
Price / Earnings n/m no net income reported
Price / Book n/m negative shareholder equity, so no book multiple, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 2, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jun 30, 2026 Reported Currency USD FYE September

Newest figures come from the 10-Q for Q3 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the GNVR SEC filings page.

This page shows Genvor Inc (GNVR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI GNVR FY2025

GNVR’s visible mechanic is a balance sheet with minimal recorded assets, negative equity, and liquidity pressure despite lower reported long-term debt.

From FY2023 to FY2025, total assets fell from $82.1K to $45.8K, while total equity remained negative. By FY2025, negative equity of -$1.3M against that small asset base indicates that conventional asset-based financial strength is not visible.

Across the latest three periods, the current ratio stayed below 0.1x, indicating persistent short-term balance-sheet tightness. Reported long-term debt nevertheless fell from $1.3M to $20K, so that reduction alone did not produce a liquid balance sheet.

Some figures from recent filings were inconsistent and were omitted from this summary.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

Genvor Inc does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.

Key Financial Metrics

Export CSV

Earnings & Revenue

EPS (Diluted)
-$0.07
YoY-600.0%
QoQ-600.0%

Genvor Inc earned -$0.07 per diluted share (EPS) in Q3 2026. This represents a decrease of 600.0% from the same quarter a year earlier. Against the prior quarter it is down 600.0%.

Revenue

Not reported for Q3 2026.

EBITDA

Not reported for Q3 2026.

Net Income

Not reported for Q3 2026.

Cash & Balance Sheet

Cash & Debt
$197K
YoY+98.6%
QoQ+107.3%

Genvor Inc held $197K in cash as of Q3 2026; long-term debt is not reported for that period.

Shares Outstanding
36M
YoY+22.9%
QoQ+0.6%

Genvor Inc had 36M shares outstanding in Q3 2026. This represents an increase of 22.9% from the same quarter a year earlier. Against the prior quarter it is up 0.6%.

Free Cash Flow

Not reported for Q3 2026.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

None of these metrics is reported for Q3 2026.

Capital Allocation

R&D Spending
$206K
YoY-24.2%
QoQ+259.9%

Genvor Inc invested $206K in research and development in Q3 2026. This represents a decrease of 24.2% from the same quarter a year earlier. Against the prior quarter it is up 259.9%.

Share Buybacks

Not reported for Q3 2026.

Capital Expenditures

Not reported for Q3 2026.

GNVR Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

GNVR quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
R&D Expenses$206K-24.2%$57K+4.4%$57K-9.9%N/A$272K+520.6%$55K+801.7%$63K+134.6%N/A
Operating IncomeN/A-$407K-$563KN/A-$578KN/AN/AN/A
EBITDAN/AN/AN/AN/A-$577KN/AN/AN/A
Interest Expense$62K+282.3%$14K-37.5%$15K+291.6%N/A$16K$23K+4666.5%$4K-76.5%N/A
Net IncomeN/A-$430K-$576KN/A-$398KN/AN/AN/A
EPS (Basic)-$0.07-600.0%N/A-$0.02+91.7%N/A-$0.01+66.7%-$0.01+75.0%-$0.24-242.9%-$0.01+75.0%
EPS (Diluted)-$0.07-600.0%-$0.010.0%-$0.02+91.7%$0.01+200.0%-$0.01+66.7%-$0.01+75.0%-$0.24-242.9%-$0.01+75.0%
Diluted Shares (Avg)36M+31.3%34M+36.1%33M+58.5%N/A27M+35.9%25M+26.6%21M+6.4%N/A

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, SG&A Expenses, Income Tax.

GNVR Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

GNVR quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$312K+168.2%$177K+740.1%$146K+459.5%$46K+28.8%$116K+394.3%$21K-37.6%$26K-89.2%$36K-56.6%
Current Assets$262K+152.4%$177K+2094.4%$146K+1056.2%$46K+111.4%$104K+1029.9%$8K-57.4%$13K-94.4%$22K-67.3%
Cash & Equivalents$197K+98.6%$95K+14690.6%$104K+17727.9%$37K+9881.5%$99K+70065.2%$641-92.8%$581-99.7%$373-99.2%
Short-Term Investments$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0
Total Liabilities$3.0M+76.7%$1.1M-49.1%$1.2M-35.4%$1.4M-22.4%$1.7M+7.6%$2.1M+84.9%$1.9M+30.2%$1.7M-2.1%
Current Liabilities$2.8M+64.3%$1.1M-49.1%$1.2M-35.4%$1.4M-22.4%$1.7M+7.6%$2.1M+84.9%$1.9M+30.2%$1.7M-2.1%
Non-Current Liabilities$212K$0$0$0$0$0$0$0
Long-Term DebtN/AN/AN/A$20K-97.8%N/AN/AN/A$905K-31.5%
Total Equity-$2.7M-70.0%-$891K+57.1%-$1.1M+42.4%-$1.3M+23.4%-$1.6M-1.8%-$2.1M-88.6%-$1.8M-54.2%-$1.7M-0.5%
Retained Earnings-$29.8M-13.1%-$27.2M-5.0%-$26.8M-4.5%-$26.2M-27.1%-$26.3M-28.7%-$25.9M-30.5%-$25.6M-34.3%-$20.6M-16.3%

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill.

GNVR Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

GNVR quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow-$305K+6.9%-$401K-463.1%-$194K-13329.3%-$156K-688.0%-$327K-281.2%-$71K-$1K+99.7%-$20K+93.1%
Depreciation & AmortizationN/AN/AN/A$1-99.8%$4590.0%$4580.0%$4580.0%$457-0.2%
Stock-Based CompensationN/AN/A$125K-97.4%N/A$63K$63K-84.6%$4.7M+422.3%N/A
Financing Cash Flow$406K-4.5%$392K+450.3%$260K+15657.6%$94K+370.4%$426K+452.1%$71K$2K-99.7%$20K-94.0%

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Investing Cash Flow, Dividends Paid, Share Buybacks.

GNVR Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

GNVR quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Return on AssetsN/A-243.0%-395.4%N/A-341.7%N/AN/AN/A
Current Ratio0.090.0x0.17+0.2x0.12+0.1x0.030.0x0.06+0.1x0.000.0x0.01-0.2x0.010.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, Asset Turnover, FCF Margin.

Note: Shareholder equity is negative (-$1.3M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.03), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Genvor Inc GNVR FY2025 N/A N/A N/A $13.5M
Purebase PUBC FY2025 $285K N/A N/A $3.5M
Sustainable Green Team Ltd SGTM FY2022 N/A $8.9M N/A $11.5M

Frequently Asked Questions

What is Genvor Inc's earnings per share (EPS)?

Genvor Inc (GNVR) reported diluted earnings per share of -$0.22 for fiscal year 2025. This represents a -46.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

How much debt does Genvor Inc have?

As of fiscal year 2025, Genvor Inc (GNVR) had $37K in cash and equivalents against $20K in long-term debt.

What are Genvor Inc's total assets?

Genvor Inc (GNVR) had $46K in total assets as of fiscal year 2025, including both current and long-term assets.

Genvor Inc (GNVR) had 35M shares outstanding as of fiscal year 2025.

Genvor Inc (GNVR) had a current ratio of 0.03 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Genvor Inc (GNVR) has no price-to-earnings ratio at the moment: no net income reported. The market capitalization is $13.5M as of Sep 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Genvor Inc (GNVR) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $13.5M as of Sep 2, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Genvor Inc (GNVR) has negative shareholder equity of -$1.3M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Back to top